ArticleNeurology(R) neuroimmunology & neuroinflammation2026
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.
Qiao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.